o(6)-benzylguanine has been researched along with Leukemia, T-Cell in 1 studies
O(6)-benzylguanine: a suicide inhibitor of O(6)-methylguanine-DNA methyltransferase activity
Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wakazono, Y | 1 |
| Kubota, M | 1 |
| Furusho, K | 1 |
| Liu, L | 1 |
| Gerson, SL | 1 |
1 other study available for o(6)-benzylguanine and Leukemia, T-Cell
| Article | Year |
|---|---|
Thymidine kinase deficient cells with decreased TTP pools are hypersensitive to DNA alkylating agents.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cell Survival; Ethyl Methanesulfonate; Gua | 1996 |